Serum total lipids, lpoprotein cholesterol, and apolipoprotein A in acute viral hepatitis used. 2 ul serum sample diluted 1:40 with buffer was applied in 2 mm diameter wells, and the electrophoresis was run for six hours at 14 V/cm in a cooled chamber, after which the gel was thoroughly washed in phosphate-buffered saline, dried, and stained with Coomassie brilliant blue R (Sigma Chemical Co, St. Louis, Ohio, USA). 
Results
In controls, the normal range, based upon the 10th and 90th percentiles, was 78-128% for Apo A, 146-230 mg/100 ml for total cholesterol, and 58-145 mg/100 ml for total triglycerides. A serial dilution (1:20, 1:40, 1:160) of pooled normal sera, frozen batchwise at -20'C and thawed only once, was used for the calibration curve. Each serum sample was tested twice. Both the within-and between-assay coefficients of variation were 5-9 %. Bidimensional immunoelectrophoresis was carried out according to Ganrot (1972) Total bilirubin, direct bilirubin, y-glutamyltransferase (y-GT), alanine aminotransferase (SGPT), alkaline phosphatase, albumin, and IgG, IgA, and IgM were determined in the serum according to standard laboratory techniques. Bile acids were measured according to Schwarz et al. (1974) . The coefficient of regression, mean, standard deviation, and Student's test of significance were calculated by standard techniques (Snedecor and Cochran, 1967 (Fig. 6 ). Apo A was negatively correlated with triglycerides, log SGPT, log total bilirubin, and bile acids. Triglycerides were positively correlated with log SGPT and log direct bilirubin and negatively correlated with HDL-chol. Table 1 summarises these results.
In chronic liver disease triglyceride levels were not modified (Fig. 7) . We also observed a clear trend towards low levels of total cholesterol (Fig. 8) and Apo A (Fig. 9) , reflecting the severity of liver injury. The absence of a and pre ,8 lipoproteins, and very low concentrations of total cholesterol and Apo A were found in hepatic coma. Primary biliary cirrhosis behaved quite differently, in that total cholesterol was high, LP-X was present, and Apo A was nearly normal in five out of eight patients. Thalassinos et al., 1975; Vogt and Englhardt, 1975) . The absence of a lipoprotein has been attributed to the impaired lipid-binding capacity of Apo A (Seidel et al., 1972) . According to our results, Apo A is decreased during the early phase of the disease and its cholesterol content is normal. In bidimensional immunoelectrophoresis we were also able to see a decrease of Apo A. In normal subjects Apo A shows one peak with an anodal shoulder (Fig. 1Oa ). In the early phase of acute hepatitis the peak is greatly reduced while ai antitrypsin, an acute phase reactant protein synthesised by the liver, which was used as a marker, increases (Fig. lOb) . During recovery the Apo A peak returns towards a near normal height (Fig. IOc) . Because in acute hepatitis the synthetic capacity of the liver is not impaired, the low level of Apo A is probably due to an increased catabolism of the apolipoprotein after reduction of LCAT activity described by several authors (Simon and Scheig, 1970; Calandra et al., 1971; Gjone et al., 1971) in acute hepatitis.
The mechanism of LCAT deficiency in acute viral hepatitis is obscure; it could be related to bile salt interactions with apoprotein activator or to subtle derangement in lipoprotein metabolism (Sabesin et al., 1977) .
It seems probable that LCAT plays a necessary role in the normal conversion of the nascent HDL to the 'mature' HDL (Hamilton, 1972) . Electron microscopic studies of HDL in acute alcoholic liver disease revealed the presence of stacked discs, which resemble nascent HDL (Sabesin et al., 1977) . The same modification present in acute hepatitis, such as hypertriglyceridaemia, absence of a lipoprotein, and presence of f3-VLDL, has been reported in familial LCAT deficiency (Norum and Gjone, 1967) . Because Apo A-I (R-gln-I) is an activator of LCAT (Fielding et al., 1972) , a decrease of Apo A may in turn impair LCAT activity. Apo C-II (R-glu), which is exchanged between HDL and VLDL (Eisenberg and Levy, 1975) , is an activator of the lipoprotein lipase (LaRosa et al., 1970) . A reduced recycling, due to a deficiency of Apo A, may cause an impairment of the enzyme activity, which results in hypertriglyceridaemia.
Apo A is a trace component of VLDL. According to Levy et al. (1966) , the pre mobility of normal VLDL is derived from its Apo A component.
There is evidence that the electrophoretic mobility of VLDL returns to normal when acted upon by LCAT (Seidel et al., 1972; Glomset and Norum, 1973) . The abnormal LDL that we found in four patients with marked cholestasis has been described by Klor et al. (1972) as LDL III and by Muller et al. (1974) as #2-LP. Muller et al. (1974) The prognostic value of these parameters during the course of acute viral hepatitis has been pointed out (Thalassinos et al., 1975) . In chronic liver disease, impairment of the synthetic ability of the liver, as indicated by routine biochemical tests, was associated with low levels of total cholesterol and Apo A. Increased levels of cholesterol in primary biliary cirrhosis have been attributed to LP-X (Seidel et al., 1969; Vergani et al., 1973) . Protein synthesis is enhanced in cholestatic liver tissue (Stakeberg et al., 1974) , which may explain the nearly normal levels of Apo A found in some patients with primary biliary cirrhosis. High levels of a lipoprotein in primary biliary cirrhosis have been reported by Blomhoff et al. (1974) . Cross-incubation studies showed that cholestatic serum stimulates LCAT activity (Kepkay et al., 1973) . This effect has been related to the presence of LP-X, which may act as an unusually good substrate (Kepkay et al., 1973) . However, the normal levels found in primary biliary cirrhosis of Apo A, which is the preferable substrate for LCAT (Glomset and Norum, 1973) , may explain the enhanced enzyme activation. 
